Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1999
09/07/1999US5948901 Antisense oligonucleotides for aromatase inhibition
09/07/1999US5948898 Methoxyethoxy oligonucleotides for modulation of protein kinase C expression
09/07/1999US5948896 Processes for preparing 13-deoxy anthracycline derivatives
09/07/1999US5948884 Cyclic peptide with substituents on the methylene group of sarcosine in position 3 of cyclosporin; viricide against human immunodeficiency virus without immunosuppressive effect
09/07/1999US5948824 Use of a chemical agent for reducing the changes in waistline and the effect of constipation due to the taking of other agents
09/07/1999US5948823 Irradiation protection method
09/07/1999US5948822 Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
09/07/1999US5948821 Methods of using ajoene
09/07/1999US5948818 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
09/07/1999US5948815 Using genistein
09/07/1999US5948814 Genistein for the treatment of cystic fibrosis
09/07/1999US5948813 Method of preventing allograft rejection
09/07/1999US5948811 Psychological disorders; parkinson's disease
09/07/1999US5948810 Use of R-(+)-α-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae
09/07/1999US5948809 (-) cis-6(S)-phenyl-5(R) 4-(2-pyrrolidin-1-yl ethoxy) phenyl!-5,6,7,8-tetrahydronaphthalen-2-ol-D-tartrate
09/07/1999US5948806 Treatment of Parkinson's disease with (+)2-(ethyl-2,3-dihydrobenzofuranyl)-2-Imidazoline (dexefaroxan or (+) efaroxan)
09/07/1999US5948804 Anaesthetic premedication
09/07/1999US5948803 Improve the insulin resistance and have potent hypoglycemic effect and lipid-lowering effect
09/07/1999US5948802 Stroke, anticonvulsants, antiepilepic agents, antiasthma agents, migraines, nervous system disorders, sexual disorders, incotinence
09/07/1999US5948801 Treatment of retinal edema with brinzolamide
09/07/1999US5948800 Preventive or therapeutic drug for Alzheimer's disease
09/07/1999US5948799 Method for improving morbidity and/or mortality
09/07/1999US5948796 Benzo B!thiophene compounds, intermediates, formulations, and methods
09/07/1999US5948795 Benzothiopene compounds, and uses and formulations thereof
09/07/1999US5948794 Enterokinetic benzamide
09/07/1999US5948791 Quinoline derivatives for treating malaria
09/07/1999US5948790 Retroviral protease inhibitors
09/07/1999US5948789 Process for synthesis of substituted sulphoxides
09/07/1999US5948788 Normorphine and normorphinone derivatives
09/07/1999US5948787 Mixture of morphine sulfate and surfactant
09/07/1999US5948786 Blocking tumor necrosis factor
09/07/1999US5948784 Nephritis
09/07/1999US5948782 Antiinflammatory agent; rheumatic diseases
09/07/1999US5948781 Adamantyl substituted oxindoles as pharmaceutical agents
09/07/1999US5948780 Administering a metalloproteinase inhibitor
09/07/1999US5948778 Difluoro statone antiviral analogs
09/07/1999US5948777 Cannabinoid receptor agonists
09/07/1999US5948776 Compounds containing two aromatic systems covalently linked through a linker containing one or more atoms, or ?linker? defined as including a covalent bond per se so as to space the aromatic systems at a distance 1.5-15 ang.
09/07/1999US5948773 Formulation comprising antibacterial substance and antiulcer substance
09/07/1999US5948772 Useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
09/07/1999US5948771 Method for treating heart failure using tetrapyrroles and metallotetrapyrroles
09/07/1999US5948769 Orally administering to a mammal in need thereof a composition comprising 80 to 800 mg vitamin e, an effective amount of salicylic acid ester, and a pharmaceutically acceptable carrier or adjuvant.
09/07/1999US5948768 Treatment of otitis media by sublingual administration of DNA
09/07/1999US5948767 Transport of active material into cells; drug delivery
09/07/1999US5948766 Use of tasteless, hydrolyzed collagen and agent containing the same
09/07/1999US5948762 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor or a nitric oxide inhibitor
09/07/1999US5948675 Host-vector system which can be used in gene therapy
09/07/1999US5948669 As probes and primers; for diagnosis and treatment of osteoporosis, oral diseases, paget's disease; antiarthritic agents, anticarcinogenic/antitumor/antimetastasis agents
09/07/1999US5948642 Polynucleotide from staphylococcus aureus which codes for resolvase polypeptide; for diagnosis of infections; as bactericides; for screening for novel antibiotics; treatment of toxic shock syndrome
09/07/1999US5948640 Mammalian additional sex combs (mammalian Asx) acts as a tumor suppressor
09/07/1999US5948626 Method of detecting human phospholipase inhibitor
09/07/1999US5948440 Modified release matrix formulation of cefaclor and cephalexin
09/07/1999US5948437 Pharmaceutical compositions using thiazepine
09/07/1999US5948436 Protease inhibitor
09/07/1999US5948435 Methods of regulating CETP genes, enzymes and other compound, and pharmaceutical composition therefor
09/07/1999US5948434 Administering dehydroepiandrosterone or dehydroepiandrosterone sulphate via transdermal patch
09/07/1999US5948428 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
09/07/1999US5948422 Oral dosage-forms containing a β-lactam antibiotic
09/07/1999US5948418 Mercaptans
09/07/1999US5948405 Fucans with low molecular weight having anticoagulant, antithrombinic and antithromobic activity
09/07/1999US5948401 Cationic therapeutic systems
09/07/1999US5948390 Hydrated zinc cations; fully or partially protonated citrate moieties; cetyl pyridinium cations; and orally acceptable vehicle
09/07/1999CA2168563C Benzopyrans and pharmaceutical compositions containing them
09/07/1999CA2167257C Use of sertraline to treat cancer patients
09/07/1999CA2148780C Use of active principles protected against rumen degradation as hepatoprotectors
09/07/1999CA2147881C Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases
09/07/1999CA2136042C 3-(7'-oxo-1'-aza-4'-oxabicyclo¬3.2.0| hept-3'-yl) propionic acid derivative
09/07/1999CA2098944C Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present
09/07/1999CA2046313C Platinum (ii) complex and agent for treating malignant tumor
09/07/1999CA2016646C Arylsulphonamides
09/07/1999CA2014884C 5,11-dihydro-6h-pyrido[2,3-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of aids
09/07/1999CA2014008C Benzimidazoles, medicaments containing these compounds and processes for their preparation
09/07/1999CA2006119C Anti-aids viral agents and anticancer action
09/07/1999CA2004166C Implant for use in bone surgery
09/07/1999CA1340722C Pharmaceutical composition for the treatment of high blood pressure
09/07/1999CA1340721C 1,4-dihydro-quinoline-and naphthyridine-3-carboxylic acid antibacterial agents
09/05/1999CA2264431A1 Canine factor viii gene, protein and methods of use
09/05/1999CA2261543A1 Anti-cellulite pantyhose
09/04/1999CA2231080A1 Concentrated solutions of a 1,3,5-triazine derivative sunscreen and their use for the preparation of cosmetic compositions
09/04/1999CA2231079A1 Sun protecting cosmetic compositions comprising derivatives of dibenzoylmethane, of benzophenone and of triazine
09/04/1999CA2231005A1 Cyclin dependent kinase inhibitor
09/02/1999WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy
09/02/1999WO1999043832A2 Human proteinase molecules
09/02/1999WO1999043814A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity
09/02/1999WO1999043698A1 Substance having steroid-like structure, process for the production thereof and antitumor agents containing the same
09/02/1999WO1999043693A1 36 human secreted proteins
09/02/1999WO1999043692A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE
09/02/1999WO1999043691A1 2'-fluoronucleosides
09/02/1999WO1999043680A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
09/02/1999WO1999043678A1 Remedies/preventives for parkinson's disease
09/02/1999WO1999043677A1 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE
09/02/1999WO1999043676A2 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines
09/02/1999WO1999043675A1 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines
09/02/1999WO1999043672A1 Inhibitors of phospholipase a2
09/02/1999WO1999043671A1 Substituted aminomethyl isoxazoline derivatives useful as antimicrobials
09/02/1999WO1999043670A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
09/02/1999WO1999043665A1 Process for the preparation of simvastatin and derivatives thereof
09/02/1999WO1999043664A1 Heterocyclic diarylmethylene derivatives, methods of preparing them and their uses in therapeutics
09/02/1999WO1999043663A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
09/02/1999WO1999043661A2 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands